Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Traditional and nontraditional cardiovascular risk factors and estimated risk for coronary artery disease in renal transplant recipients: a single-center experience.

Banas MC, Banas B, Orth SR, Langer V, Reinhold SW, Weingart C, Jung B, Krüger B, Krämer BK.

Nephron Clin Pract. 2011;119(3):c227-35. doi: 10.1159/000327616. Epub 2011 Aug 18.

PMID:
21849798
2.

Smoking is a risk factor in the progression to kidney failure.

Hallan SI, Orth SR.

Kidney Int. 2011 Sep;80(5):516-23. doi: 10.1038/ki.2011.157. Epub 2011 Jun 15.

3.

Sympathetic blockade prevents the decrease in cardiac VEGF expression and capillary supply in experimental renal failure.

Amann K, Odoni G, Benz K, Campean V, Jacobi J, Hilgers KF, Hartner A, Veelken R, Orth SR.

Am J Physiol Renal Physiol. 2011 Jan;300(1):F105-12. doi: 10.1152/ajprenal.00363.2010. Epub 2010 Oct 20.

4.

The conundrum of chronic kidney disease classification and end-stage renal risk prediction in the elderly--what is the right approach?

Hallan SI, Orth SR.

Nephron Clin Pract. 2010;116(4):c307-16. doi: 10.1159/000319166. Epub 2010 Jul 24. Review.

5.

The KDOQI 2002 classification of chronic kidney disease: for whom the bell tolls.

Hallan SI, Orth SR.

Nephrol Dial Transplant. 2010 Sep;25(9):2832-6. doi: 10.1093/ndt/gfq370. Epub 2010 Jul 1. No abstract available.

PMID:
20601368
6.

[Complementation of eGFR by urinary albumin excretion - the way to a new classification system of chronic kidney disease].

Orth SR, Hallan SI.

Dtsch Med Wochenschr. 2010 Jun;135(24):1241-6. doi: 10.1055/s-0030-1255144. Epub 2010 Jun 8. Review. German. No abstract available.

PMID:
20533159
7.

Combining GFR and albuminuria to classify CKD improves prediction of ESRD.

Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR.

J Am Soc Nephrol. 2009 May;20(5):1069-77. doi: 10.1681/ASN.2008070730. Epub 2009 Apr 8.

8.

Smoking behaviour of patients before and after renal transplantation.

Banas MC, Banas B, Wolf J, Hoffmann U, Krüger B, Böger CA, Orth SR, Krämer BK.

Nephrol Dial Transplant. 2008 Apr;23(4):1442-6. Epub 2007 Dec 8.

PMID:
18065794
10.
11.

Blood pressure-independent effect of long-term treatment with the soluble heme-independent guanylyl cyclase activator HMR1766 on progression in a model of noninflammatory chronic renal damage.

Benz K, Orth SR, Simonaviciene A, Linz W, Schindler U, Rütten H, Amann K.

Kidney Blood Press Res. 2007;30(4):224-33. Epub 2007 Jun 15.

12.

Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus.

Orth SR, Schroeder T, Ritz E, Ferrari P.

Nephrol Dial Transplant. 2005 Nov;20(11):2414-9. Epub 2005 Jul 26.

PMID:
16046507
13.
14.

Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors.

Ogata H, Ritz E, Odoni G, Amann K, Orth SR.

J Am Soc Nephrol. 2003 Apr;14(4):959-67.

15.

Smoking and dialysis: a dreadful scenario for the cardiovascular system?

Orth SR, Uehlinger DE.

Kidney Int. 2003 Apr;63(4):1580-1. Review. No abstract available.

16.
17.
18.

Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes?

Viedt C, Orth SR.

Nephrol Dial Transplant. 2002 Dec;17(12):2043-7. Review. No abstract available.

PMID:
12454208
19.

Adverse effect of smoking on renal function in the general population: are men at higher risk?

Orth SR, Ritz E.

Am J Kidney Dis. 2002 Oct;40(4):864-6. Review. No abstract available.

PMID:
12324927
20.

The renal risks of smoking: an update.

Orth SR, Ritz E.

Curr Opin Nephrol Hypertens. 2002 Sep;11(5):483-8. Review.

PMID:
12187311
21.

Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1.

Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kübler W, Kreuzer J.

Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):914-20.

PMID:
12067898
22.

Smoking and the kidney.

Orth SR.

J Am Soc Nephrol. 2002 Jun;13(6):1663-72. No abstract available.

23.
24.

Cigarette smoke condensate aggravates renal injury in the renal ablation model.

Odoni G, Ogata H, Viedt C, Amann K, Ritz E, Orth SR.

Kidney Int. 2002 Jun;61(6):2090-8.

25.
26.

[Adverse renal effects of legal and illicit drugs].

Orth SR.

Ther Umsch. 2002 Mar;59(3):122-30. Review. German.

PMID:
11975400
27.

Cigarette smoking: an important renal risk factor - far beyond carcinogenesis.

Orth SR.

Tob Induc Dis. 2002 Jun 15;1(2):137-55. doi: 10.1186/1617-9625-1-2-137.

28.

Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers.

Amann K, Koch A, Hofstetter J, Gross ML, Haas C, Orth SR, Ehmke H, Rump LC, Ritz E.

Kidney Int. 2001 Oct;60(4):1309-23.

29.

Specific organ protection by blocking the renin-angiotensin system.

Orth SR, Ritz E.

Nephrol Dial Transplant. 2001;16 Suppl 6:40-2. Review. No abstract available.

PMID:
11568238
30.

Adverse effects of smoking in the renal patient.

Orth SR, Viedt C, Ritz E.

Tohoku J Exp Med. 2001 May;194(1):1-15. Review.

31.

Pharmacological intervention in progressive renal diseases.

Orth SR, Schömig M, Ritz E.

Nephrol Dial Transplant. 2001;16 Suppl 5:19-25. Review. No abstract available.

PMID:
11509680
32.

Sympathetic overactivity and arterial hypertension in renal failure.

Orth SR, Amann K, Strojek K, Ritz E.

Nephrol Dial Transplant. 2001;16 Suppl 1:67-9. Review.

PMID:
11369825
33.

Endothelin in renal diseases and cardiovascular remodeling in renal failure.

Orth SR, Viedt C, Amann K, Ritz E.

Intern Med. 2001 Apr;40(4):285-91. Review.

34.

Adult human mesangial cells (HMCs) express endothelin-B-receptors which mediate endothelin-1-induced cell growth.

Orth SR, Amann K, Gehlen F, Unger L, Wagner J, Raschack M, Ritz E.

J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S232-7.

PMID:
11078385
35.

Smoking--a risk factor for progression of renal disease.

Orth SR.

Kidney Blood Press Res. 2000;23(3-5):202-4. Review. No abstract available.

PMID:
11031722
36.

Smoking and the kidney.

Orth SR, Ogata H, Ritz E.

Nephrol Dial Transplant. 2000 Oct;15(10):1509-11. Review. No abstract available.

PMID:
11007813
37.

Smoking--a renal risk factor.

Orth SR.

Nephron. 2000 Sep;86(1):12-26. Review.

PMID:
10971149
38.

Smoking: a factor promoting onset and progression of diabetic nephropathy.

Ritz E, Ogata H, Orth SR.

Diabetes Metab. 2000 Jul;26 Suppl 4:54-63. Review.

PMID:
10922974
39.

Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.

Amann K, Rump LC, Simonaviciene A, Oberhauser V, Wessels S, Orth SR, Gross ML, Koch A, Bielenberg GW, Van Kats JP, Ehmke H, Mall G, Ritz E.

J Am Soc Nephrol. 2000 Aug;11(8):1469-78.

40.

Smoking as a risk factor for end-stage renal failure in patients with primary renal disease.

Orth SR, Odoni G, Ogata H, Ritz E.

Contrib Nephrol. 2000;130:109-23. No abstract available.

PMID:
10892557
41.

Acute effects of cigarette smoking on renal hemodynamics.

Ritz E, Benck U, Orth SR.

Contrib Nephrol. 2000;130:31-8. Review. No abstract available.

PMID:
10892548
42.

The cultural history of smoking.

Ritz E, Orth SR.

Contrib Nephrol. 2000;130:1-10. No abstract available.

PMID:
10892545
43.

Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.

Amann K, Gassmann P, Buzello M, Orth SR, Törnig J, Gross ML, Magener A, Mall G, Ritz E.

Kidney Int. 2000 Jul;58(1):153-61.

44.
45.

Adverse effect of smoking on the renal outcome of patients with primary hypertension.

Ritz E, Orth SR.

Am J Kidney Dis. 2000 Apr;35(4):767-9. No abstract available.

PMID:
10739802
46.

Nephropathy in patients with type 2 diabetes mellitus.

Ritz E, Orth SR.

N Engl J Med. 1999 Oct 7;341(15):1127-33. Review. No abstract available.

PMID:
10511612
47.

The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" model.

Orth SR, Odoni G, Amann K, Strzelczyk P, Raschack M, Ritz E.

J Am Soc Nephrol. 1999 Feb;10(2):387-91.

48.

[Nephrotic syndrome].

Orth SR, Ritz E.

Internist (Berl). 1998 Dec;39(12):1246-52. Review. German. No abstract available.

PMID:
10198831
49.

Smoking as a risk factor for end-stage renal failure in men with primary renal disease.

Orth SR, Stöckmann A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schäfer K, Sieberth HG, Wanner C, Watschinger B, Zucchelli P.

Kidney Int. 1998 Sep;54(3):926-31.

50.

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats.

Schwarz U, Amann K, Orth SR, Simonaviciene A, Wessels S, Ritz E.

Kidney Int. 1998 Jun;53(6):1696-705.

Supplemental Content

Support Center